Infectious Diseases News and Research

RSS

New study: Children born with HIV are now faring well into adolescence, adulthood

Once facing an almost certain death sentence, most children born with HIV are now faring well into adolescence and adulthood, according to a newly published study co-authored by Tulane infectious diseases expert Dr. Russell Van Dyke. The study was published in the Journal of Acquired Immune Deficiency Syndromes.

22 Apr 2011

Rate of antiretroviral virological failure higher among children living with HIV/AIDS than adults, study finds

One in eight children living with HIV/AIDS "experiences triple-class virological failure - meaning the virus becomes resistant to multiple drugs - within five years of starting antiretroviral treatment," according to a study published Wednesday in the Lancet, HealthDay News/MSN reports. The "failure rate is higher than in adults and highlights the challenge of maintaining viral load suppression in young patients who begin antiretroviral therapy so early in life, the researchers said," according to the news service (Preidt, 4/19).

21 Apr 2011

Immigrant screening fails to detect more than 70% cases of latent tuberculosis infection

Current UK procedures to screen new immigrants for tuberculosis (TB) fail to detect more than 70 per cent of cases of latent infection, according to a new study published in The Lancet Infectious Diseases.

21 Apr 2011

Genetically modified mosquitoes tested to prevent spread of malaria: Study

According to the latest study in the journal Nature, researchers from Imperial College London and the University of Washington, Seattle found that after making specific genetic changes to a few mosquitoes and then allowing them to breed could eventually dramatically reduce the spread of the deadly disease malaria.

20 Apr 2011

ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

ARIAD Pharmaceuticals, Inc. today announced execution of three exclusive out-license agreements for separate aspects of its ARGENT™ cell-signaling regulation technology.

20 Apr 2011

Cmed Group selected to help PDPs develop new medicines in Third-World Countries

Cmed Group, an innovative clinical trials services and advanced software provider, announced today that it has been selected as one of six preferred providers offering its clinical research expertise to a consortium of 14 global health Product Development Partnerships (PDPs). The PDPs are working to develop and deliver affordable treatments and vaccines that will help improve the lives of the some of the world's most vulnerable people, especially those in developing countries.

20 Apr 2011

Furiex acquires full rights to JNJ-Q2, a novel broad-spectrum fluoroquinolone antibiotic

Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.

20 Apr 2011

Durata commences dalbavancin Phase 3 study in acute bacterial skin and skin structure infections

Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).

20 Apr 2011

Researchers to wind down HIV prevention trial in women after interim results find drug not offering protection from HIV

Researchers on Monday announced they were calling off a trial to test whether taking an oral HIV drug reduces the risk of HIV infection in women after interim analysis of the study showed women taking the medication were no less likely to become infected with HIV than those who were not taking the medicine, the Associated Press reports.

20 Apr 2011

U.N. General Assembly passes resolution urging renewed efforts to fight malaria

Ahead of World Malaria Day on April 25, the U.N. General Assembly on Monday adopted a resolution urging governments, U.N. agencies, nongovernmental organizations (NGOs), and private foundations to accelerate their efforts and build upon established successes in the fight against the disease, particularly in Africa, Deutsche Presse-Agentur/M&C reports.

20 Apr 2011

Researchers find relation between strain of tuberculosis and Canadian fur trade

Researchers have found that a strain of tuberculosis responsible for devastating some isolated Aboriginal populations in Canada was first introduced to these communities by French Canadian fur traders between 1710 and 1870.

20 Apr 2011

Opinions: Cambodian aid; Tobin tax; Japan recovery; Inflation, infectious disease in Asia

In a Washington Post opinion piece, Joel Brinkley, a professor of journalism at Stanford University who authored a book about Cambodia, writes about a donor-pledge meeting in Cambodia scheduled for Wednesday and discusses a potential law that would require NGOs to register with the government.

20 Apr 2011

EraGen, Applied BioCode partner to commercialize molecular diagnostics

Applied BioCode, Inc. and EraGen Biosciences Inc. today announced that they have entered into a strategic partnership and license agreement. The agreement provides EraGen with access to Applied BioCode's Barcoded Magnetic Bead technology and the CE-marked BioCode-1000 system.

19 Apr 2011

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Johnson & Johnson today announced sales of $16.2 billion for the first quarter of 2011, an increase of 3.5% as compared to the first quarter of 2010.

19 Apr 2011

Commonly used strategy has no effect in reducing MRSA, VRE in hospital ICUs

A new research study of the effect of a commonly used strategy to reduce the spread of antibiotic-resistant bacteria in hospital intensive care units shows that the strategy had no significant effect. That's the surprising finding of a multisite study led by Mayo Clinic investigators.

19 Apr 2011

Groundbreaking news on Dengue

Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.

18 Apr 2011

Quest Diagnostics launches AccuType IL28B test for HCV

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection.

From Quest Diagnostics 18 Apr 2011

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today it has signed a collaboration agreement with Transgene S.A. and ChronTech Pharma AB to evaluate a novel therapeutic vaccination strategy against genotype 1 hepatitis C virus in a phase I clinical study.

18 Apr 2011

Measles alert issued in Tasmania

Tasmanian health authorities have issued an alert over a measles case. They issued a statement revealing that a woman who travelled to Devonport on the Spirit of Tasmania on Monday has been diagnosed with the infectious disease. She was one of four people to contract measles while on board an Air Asia flight from Kuala Lumpur to Melbourne.

17 Apr 2011

Drug resistant bug plaguing the meat industry: Study

It has been found that nearly half of the meat and poultry (47 percent) sold in U.S. grocery stores is contaminated with Staphylococcus aureus (“Staph”), a bacteria linked to a wide range of human diseases, and this bacteria is resistant to at least three classes of antibiotics in more than half (52 percent) of contaminated samples. This comes from a nationwide study by the Translational Genomics Research Institute (TGen) published this week in the journal Clinical Infectious Diseases.

17 Apr 2011

Infectious Diseases News and Research

New study: Children born with HIV are now faring well into adolescence, adulthood

Rate of antiretroviral virological failure higher among children living with HIV/AIDS than adults, study finds

Immigrant screening fails to detect more than 70% cases of latent tuberculosis infection

Genetically modified mosquitoes tested to prevent spread of malaria: Study

ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

Cmed Group selected to help PDPs develop new medicines in Third-World Countries

Furiex acquires full rights to JNJ-Q2, a novel broad-spectrum fluoroquinolone antibiotic

Durata commences dalbavancin Phase 3 study in acute bacterial skin and skin structure infections

Researchers to wind down HIV prevention trial in women after interim results find drug not offering protection from HIV

U.N. General Assembly passes resolution urging renewed efforts to fight malaria

Researchers find relation between strain of tuberculosis and Canadian fur trade

Opinions: Cambodian aid; Tobin tax; Japan recovery; Inflation, infectious disease in Asia

EraGen, Applied BioCode partner to commercialize molecular diagnostics

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Commonly used strategy has no effect in reducing MRSA, VRE in hospital ICUs

Groundbreaking news on Dengue

Quest Diagnostics launches AccuType IL28B test for HCV

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Measles alert issued in Tasmania

Drug resistant bug plaguing the meat industry: Study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News